Oramed Pharmaceuticals
ORMP
#9041
Rank
C$0.12 B
Marketcap
$3.10
Share price
-3.86%
Change (1 day)
-7.01%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): -C$0.14 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of C$9.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 C$0.48 M-95.05%
2023 C$9.85 M-119.45%
2022 -C$50.67 Million39.17%
2021 -C$36.41 Million73.93%
2020 -C$20.94 Million18.53%
2019 -C$17.66 Million-16.62%
2018 -C$21.18 Million38.32%
2017 -C$15.32 Million12.51%
2016 -C$13.61 Million25.01%
2015 -C$10.89 Million18.18%
2014 -C$9.22 Million39.72%
2013 -C$6.6 Million46.4%
2012 -C$4.51 Million128.32%
2011 -C$1.98 Million-51.47%
2010 -C$4.07 Million35.21%
2009 -C$3.01 Million
2007 -C$4.73 Million607.04%
2006 -C$0.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.7 Billion-143,030.59%๐Ÿ‡บ๐Ÿ‡ธ USA
C$26.19 B 5,365,367.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
C$12.14 B 2,487,273.94%๐Ÿ‡ซ๐Ÿ‡ท France
-C$13.43 Million-2,850.42%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-C$0.28 Billion-56,871.39%๐Ÿ‡บ๐Ÿ‡ธ USA